Finorify

CAI

Caris Life Sciences

$16.46-5.76%

Price

CAI daily closing price
Market cap
$4.65 billion
P/E (TTM)
201
EV/EBITDA
62.07
Volume
3.0M
Sector
Healthcare

Caris Life Sciences (CAI) last closed at $16.46, on a daily price path from October 21, 2025 to October 21, 2026. Overview is that price path. Performance is the change in the close over the periods Finorify shows on the stock screen. Financials, cash flow, and margins come from reported quarters. Valuation lists the latest ratios. This snapshot is the Finorify stock screen for CAI, covered for search and blurred for visitors.

Performance

  • 1D+3.99%
  • 5D+6.92%
  • 1M+2.80%
  • 3M+106.71%
  • 6M+57.80%
  • 1Y+2.70%

Financials

CAI revenueQ2 '25Q3 '25Q1 '26Q2 '26

Over the latest four reported periods ending June 30, 2026, Caris Life Sciences reported revenue of $696.7 million.

The prior window totaled $181.4 million, so the latest window is higher than that stretch.

Operating cash flow in the latest window was $123.8 million.

Free cash flow in the latest window was $84.3 million.

These amounts are taken from Caris Life Sciences's SEC filings and are a snapshot as of August 14, 2026. They are not a live price, and they are not a recommendation to buy or sell. Finorify uses the same filings to draw the charts inside the app.

A few ratios from those statements: Profitability: ROE -0.1% (3 of 100). Leverage: D/E 0.66× (73 of 100). Cash generation: FCF margin 12.1% (24 of 100). Net margin: -0.2% (0 of 100). Liquidity: Current 5.53× (100 of 100).

Cash Flow

CAI free cash flowQ2 '25Q3 '25Q1 '26Q2 '26

Margins

CAI operating margin

Valuation

P/E (TTM)
201
P/S (TTM)
6.68
EV/EBITDA
62.07

Insights

Finorify has not written notes for CAI in this snapshot.

Read the live analysis in Finorify

Charts, news, and the written notes are in the app. You can open five distinct stocks free. After that, the stock screen is a Finorify Pro feature.

Open CAI in Finorify